Statement Of Financial Position [Abstract]

Zealand Pharma - Filing #5889383

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	46,479,000 DKK	—	—	—	—	—	—	47,047,000 DKK	—	—	—	—	—
Right-of-use assets	—	—	78,768,000 DKK	—	—	—	—	—	—	102,805,000 DKK	—	—	—	—	—
Intangible assets other than goodwill	—	—	12,620,000 DKK	—	—	—	—	—	—	12,255,000 DKK	—	—	—	—	—
Deferred tax assets	—	—	985,000 DKK	—	—	—	—	—	—	925,000 DKK	—	—	—	—	—
Cash and cash equivalents	—	—	480,303,000 DKK	—	—	—	—	—	—	449,311,000 DKK	1,069,234,000 DKK	—	—	—	—
Assets	—	—	9,505,600,000 DKK	—	—	—	—	—	—	1,979,993,000 DKK	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	71,024,000 DKK	—	—	—	—	—	—	58,751,000 DKK	—	—	—	—	—
Retained earnings	—	—	6,157,441,000 DKK	—	—	—	—	—	—	4,894,841,000 DKK	—	—	—	—	—
Share premium	—	—	14,680,771,000 DKK	—	—	—	—	—	—	6,406,225,000 DKK	—	—	—	—	—
Equity	6,157,441,000 DKK	14,680,771,000 DKK	8,616,742,000 DKK	71,024,000 DKK	22,388,000 DKK	6,406,225,000 DKK	58,751,000 DKK	22,704,000 DKK	4,894,841,000 DKK	1,592,839,000 DKK	815,911,000 DKK	4,921,232,000 DKK	51,702,000 DKK	14,617,000 DKK	4,171,640,000 DKK
Liabilities [abstract]
Liabilities	—	—	888,858,000 DKK	—	—	—	—	—	—	387,154,000 DKK	—	—	—	—	—
Equity and liabilities	—	—	9,505,600,000 DKK	—	—	—	—	—	—	1,979,993,000 DKK	—	—	—	—	—